Future Italian Nucleic Acid Testing Market OutlookVenture Planning GroupFebruary 14, 2012 850 Pages - SKU: VPG6823382 |
|
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2013 Potentially any disease-causing gene, cell type or tissue can be targeted with miRNA, RNAi or siRNA, including those not ’druggable’ with small molecules or
|
read more...
|
$3,746.25
|
|
Antisense Therapeutics Limited – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
Antisense Therapeutics Limited – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Antisense Therapeutics Limited - Product Pipeline Review - 2013” provides data on the Antisense Therapeutics Limited’s research and development focus. The report
|
read more...
|
$1,500.00
|
|
2012 Oncology Market Research Review
12/1/2012 | published by: BCC Research
This Oncology Market Research Review provides:
An overview of the global market for microRNA diagnostics and therapeutics, with an analysis of the commercial potential of this research field. Analysis of the emerging botanical drug industry
|
read more...
|
$950.00
|
|
Future Horizons in the Italian Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
Highlights
Comprehensive 850-page market segmentation analysis of the Italian NAT market.
Major issues pertaining to the Italian NAT laboratory practice,
|
read more...
|
$5,900.00
|
|
Future Horizons in the Spanish Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
Highlights Comprehensive 850-page market segmentation analysis of the Spanish NAT market. Major issues pertaining to the Spanish NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant
|
read more...
|
$5,900.00
|
|
Future Horizons in the UK Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
Highlights Comprehensive 855-page market segmentation analysis of the UK NAT market. Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends
|
read more...
|
$5,900.00
|
|
Future Horizons in the US Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
Highlights Comprehensive 880-page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant
|
read more...
|
$8,400.00
|
|
Analysis of Nucleic Acid Testing Instrumentation And Strategic Profiles of Leading Suppliers
9/27/2012 | published by: Venture Planning Group
This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available
|
read more...
|
$3,500.00
|
|
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets
10/1/2012 | published by: BCC Research
An overview of the specific applications for nucleic acid aptamers for therapeutic and diagnostic purposes, with a focus on applications judged to be commercially viable rather than enabling of basic research
Analyses of global
|
read more...
|
$5,450.00
|
|
Disease Associations and Circulating Biomarkers
8/1/2012 | published by: Select Biosciences Limited
This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomes markets as they are evolving. In this report, we focus upon the microRNA research marketplace from the perspective
|
read more...
|
$1,970.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Antisense & RNAi Technology Reports
- Antisense Therapeutics Limited – Product Pipeline Review – 2013
- RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2013
- MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets
- RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2012
- Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets